Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma.

Author List
Middleton MR, Friedlander P, Hamid O, Daud A, Plummer R, Falotico N, Chyla B, Jiang F, McKeegan E, Mostafa NM, Zhu M, Qian J, McKee M, Luo Y, Giranda VL, McArthur GA
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1193247
Publication Year
2015
PubMed ID
26202595
Publication Title
Middleton MR, Friedlander P, Hamid O, Daud A, Plummer R, Falotico N, Chyla B, Jiang F, McKeegan E, Mostafa NM, Zhu M, Qian J, McKee M, Luo Y, Giranda VL, McArthur GA. Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma. Ann Oncol. 2015 Oct; 26(10):2173-9.
Publication Medline TA
Ann Oncol
Date
2015-07-22